Literature DB >> 6089351

Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II.

D J Slamon, K Shimotohno, M J Cline, D W Golde, I S Chen.   

Abstract

The human T-cell leukemia viruses HTLV-I and HTLV-II are unique among the transforming retroviruses of vertebrates in their ability to transform human T cells in vitro and in their close association with human malignancies (T-cell lymphomas and leukemia). Their genomes are relatively simple, containing the genes gag, pol, env, and a 3' region termed "X." This 3' region may be responsible for the transforming potential of the viruses. The existence of proteins encoded by the 3' region has been postulated on the basis of multiple open reading frames. In the present study this region is shown to contain a gene encoding a protein of 40 kilodaltons in HTLV-I and 37 kilodaltons in HTLV-II. It is proposed that these proteins be called, respectively, p40xI and p37xII.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089351     DOI: 10.1126/science.6089351

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  74 in total

1.  Studies of heterologous promoter trans-activation by the HTLV-II tax protein.

Authors:  J L Williams; A J Cann; T Leff; P Sassone-Corsi; I S Chen
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

2.  Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I.

Authors:  D J Slamon; W J Boyle; D E Keith; M F Press; D W Golde; L M Souza
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat.

Authors:  L Sherman; A Gazit; A Yaniv; T Kawakami; J E Dahlberg; S R Tronick
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Mutational analysis of human T-cell leukemia virus type 2 Tax.

Authors:  T M Ross; A C Minella; Z Y Fang; S M Pettiford; P L Green
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.

Authors:  S M Ruben; R Narayanan; J F Klement; C H Chen; C A Rosen
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

6.  Indirect binding of human T-cell leukemia virus type I tax1 to a responsive element in the viral long terminal repeat.

Authors:  S J Marriott; I Boros; J F Duvall; J N Brady
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

7.  Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA.

Authors:  T Nosaka; H Siomi; Y Adachi; M Ishibashi; S Kubota; M Maki; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  Adult T-cell leukemia-lymphoma.

Authors:  S M Neely
Journal:  West J Med       Date:  1989-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.